Published in Drug Law Weekly, March 4th, 2008
"Fifty-five isolates were tested against 14 antimicrobial agents. Decreased susceptibilities to piperacillin, metronidazole, macrolides, fluoroquinolones, and rifampin were demonstrated," wrote F. Morio and colleagues, University of Montpellier.
The researchers concluded: "The clinical impact of these decreased susceptibilities remains to be investigated but should prompt microbiologists to perform...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.